ECMO在危重型新型冠状病毒肺炎患者救治中的应用  

Application of ECMO in patients infected with Corona Virus Disease 2019

作　　者：雷鹏[1,2,3] 卢安东 潘晨亮 江尕学[1,2,3] 赵存瑞 王俊乾[1,2,3] 蔡玮婷 白明 Lei Peng;Lu An-dong;Pan Chen-liang;Jiang Ga-xue;Zhao Cun-rui;Wang Jun-qian;CaiWei-ting;Bai Ming(Heart Center,The First Hospital of Lanzhou University,Lanzhou 730000,China;Gansu Cardiovascular Disease Clinical Medical Research Center,Lanzhou 730000,China;Gansu Key Laboratory of Cardiovascular Diseases,Lanzhou 730000,China)

机构地区：[1]兰州大学第一医院心脏中心,甘肃兰州730000 [2]甘肃省心血管病临床医学研究中心,甘肃兰州730000 [3]甘肃省心血管疾病重点实验室,甘肃兰州730000

出　　处：《兰州大学学报（医学版）》2020年第2期98-102,105,共6页Journal of Lanzhou University（Medical Sciences）

基　　金：甘肃省自然科学基金资助项目(17JR5RA268)。

摘　　要：新型冠状病毒感染机体后部分病例可发展为严重的急性呼吸窘迫综合征。体外膜肺氧合(ECMO)是一种高级生命支持技术,能提高急性呼吸窘迫综合征患者的氧合,并可降低呼吸机相关肺损伤风险。本研究从ECMO启动时机、模式选择及管理等方面简要介绍ECMO在新型冠状病毒肺炎患者救治中的应用。Severe acute respiratory distress syndrome may develop in some cases after infection with SARSCoV-2.Extracorporeal membrane oxygenation(ECMO)is an advanced life support technology that improves oxygenation in acute respiratory distress syndrome patients and reduces the risk of ventilator-related lung injury.Based on certain treatment experience,this paper briefly introduced the application of ECMO in the treatment of patients infected with SARS-CoV-2 in the aspects of the starting time,mode selection and management of ECMO.

关 键 词：体外膜肺氧合 急性呼吸窘迫综合征 新型冠状病毒肺炎 

分 类 号：R459.5[医药卫生—治疗学]